Dobbins, Kathy
Addison, Carey
Roque, Autumn
El-Mallakh, Peggy L.
El-Mallakh, Rif S.
Funding for this research was provided by:
Passport Health Plan (none)
Article History
First Online: 14 November 2020
Compliance with Ethical Standards
:
: Dr. Rif El-Mallakh has research funding from Galen Pharmaceuticals. He is on the speakers’ bureaus of Indivior, Janssen, Otsuka, Sunovion, Takeda, and Teva. None of the other others have any potential conflicts of interest to report.
: This work was reviewed, approved, and overseen by the Institutional Review Board.
: All subjects provided informed consent, after reading the form and having all their questions answered.